𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Improved outcome of chronic hepatitis B after heart transplantation by long-term antiviral therapy

✍ Scribed by A. Potthoff; H. L. Tillmann; C. Bara; K. Deterding; K. Pethig; S. Meyer; A. Haverich; K. H. W. Böker; M. P. Manns; H. Wedemeyer

Book ID
108885905
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
197 KB
Volume
13
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term clinical and virological outco
Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis
✍ Didier Samuel; Anna-Linda Zignego; Michel Reynes; Cyrille Feray; Jean Louis Arul 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 874 KB

Liver transplantation for liver diseases related to hepatitis B virus (HBV) and hepatitis delta virus (HDV) remains problematic because of the risk of viral recurrence. We report here the long-term virological outcome of patients transplanted for HDV-related liver cirrhosis (HDV cirrhosis). From Dec

Long-term clinical and virological outco
Long-term clinical and virological outcomes of chronic hepatitis C after successful interferon therapy
✍ Natsuko Tsuda; Nobukazu Yuki; Kiyoshi Mochizuki; Takayuki Nagaoka; Masatoshi Yam 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 260 KB 👁 1 views

## Abstract Clinical relevance of occult hepatitis C virus (HCV) and/or hepatitis B virus (HBV) infection(s) remains uncertain years after interferon (IFN) therapy for chronic hepatitis C. By 1993, 38 sustained virological responders (SVRs) showing HCV RNA clearance at 6 months post‐treatment and 3

Mycophenolate mofetil combination therap
Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C
✍ Russell H. Wiesner; Jolene S. Shorr; Bettina J. Steffen; Alice H. Chu; Robert D. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

To evaluate the impact of mycophenolate mofetil (MMF) on long-term outcomes of tacrolimus and corticosteroids, we analyzed data reported to the Scientific Registry of Transplant Recipients for 11,670 adult patients (3463 with hepatitis C [HCV]) who underwent primary, single-organ, liver transplantat

Outcome of hepatitis B e antigen–negativ
Outcome of hepatitis B e antigen–negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine
✍ George V. Papatheodoridis; Evangelini Dimou; Konstantinos Dimakopoulos; Spilios 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB 👁 1 views

We determined the clinical outcome of hepatitis e antigen (HBeAg)-negative chronic hepatitis B patients treated with long-term nucleos(t)ide analog therapy starting with lamivudine. We evaluated 201 such patients treated for 3.8 ؎ 1.4 years and 2 historical similar cohorts: 1 treated with interferon

A simple noninvasive index for predictin
A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy
✍ Ming-Lung Yu; Shi-Ming Lin; Chuan-Mo Lee; Chia-Yen Dai; Wen-Yu Chang; Shinn-Cher 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB 👁 2 views

Changes in hepatic fibrosis after interferon-based therapy may be important in determining the long-term outcome of chronic hepatitis C (CHC). The use of liver biopsy for posttreatment assessment is not a viable option as a routine follow-up procedure. This study evaluated the predictive value of a